Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05997420 · ClinicalTrials.gov registry record · NA
Adapting a Sepsis Transition and Recovery Program for Optimal Scale Up
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,820
- Enrollment target
NCT05997420: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT05997420 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,820 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05997420, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,820 participants
- Enrollment target
Study Summary
The Adapting a Sepsis Transition and Recovery Program for Optimal Scale Up (ASTROS) study is an effectiveness-implementation hybrid design. The effectiveness evaluation is designed as a multiple interrupted time series (mITS) analysis to test the impact of implementing an adapted Sepsis Transition and Recovery (STAR) program on enhancing post sepsis outcomes in new hospital settings.
Primary Outcome
Binary composite endpoint of mortality and hospital readmission assessed 90 days post index hospital discharge
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL STAR Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,820 participants |
| Start Date | 2024-01-16 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT05997420 record still lists
NCT05997420 is an interventional study that assigns participants to a tested intervention. Its 1,820 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT05997420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05997420 about?
NCT05997420 is a clinical study titled "Adapting a Sepsis Transition and Recovery Program for Optimal Scale Up". The Adapting a Sepsis Transition and Recovery Program for Optimal Scale Up (ASTROS) study is an effectiveness-implementation hybrid design. The effectiveness evaluation is designed as a multiple interrupted time series (mITS) analysis to test the impact of implementing an adapted Sepsis Transition a...
What is the current status of trial NCT05997420?
This trial is currently completed. It is a NA study. The enrollment target is 1,820 participants. The study started on 2024-01-16. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05997420?
The interventions under investigation include: Usual Care (BEHAVIORAL), STAR Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05997420?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05997420's enrollment target sits among peer trials
1,820 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI